nodes	percent_of_prediction	percent_of_DWPC	metapath
Ivacaftor—CYP3A4—Thiotepa—sarcoma	0.167	0.202	CbGbCtD
Ivacaftor—ABCB1—Dactinomycin—sarcoma	0.134	0.162	CbGbCtD
Ivacaftor—ABCB1—Mitoxantrone—sarcoma	0.12	0.145	CbGbCtD
Ivacaftor—ABCB1—Vincristine—sarcoma	0.0823	0.0996	CbGbCtD
Ivacaftor—ABCB1—Etoposide—sarcoma	0.0754	0.0913	CbGbCtD
Ivacaftor—CYP3A4—Mitoxantrone—sarcoma	0.0716	0.0868	CbGbCtD
Ivacaftor—ABCB1—Doxorubicin—sarcoma	0.0514	0.0623	CbGbCtD
Ivacaftor—CYP3A4—Vincristine—sarcoma	0.0493	0.0597	CbGbCtD
Ivacaftor—CYP3A4—Etoposide—sarcoma	0.0452	0.0547	CbGbCtD
Ivacaftor—CYP3A4—Doxorubicin—sarcoma	0.0308	0.0373	CbGbCtD
Ivacaftor—Bilirubin total increased—Epirubicin—sarcoma	0.00693	0.0398	CcSEcCtD
Ivacaftor—Bilirubin total increased—Doxorubicin—sarcoma	0.00641	0.0368	CcSEcCtD
Ivacaftor—Blood glucose increased—Mitoxantrone—sarcoma	0.00583	0.0335	CcSEcCtD
Ivacaftor—Mastitis—Epirubicin—sarcoma	0.00569	0.0327	CcSEcCtD
Ivacaftor—Transaminases increased—Thiotepa—sarcoma	0.00568	0.0326	CcSEcCtD
Ivacaftor—Mastitis—Doxorubicin—sarcoma	0.00527	0.0303	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Thiotepa—sarcoma	0.00365	0.021	CcSEcCtD
Ivacaftor—Musculoskeletal chest pain—Epirubicin—sarcoma	0.00359	0.0206	CcSEcCtD
Ivacaftor—Musculoskeletal chest pain—Doxorubicin—sarcoma	0.00332	0.0191	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Mitoxantrone—sarcoma	0.00315	0.0181	CcSEcCtD
Ivacaftor—Hepatic enzyme increased—Mitoxantrone—sarcoma	0.00315	0.0181	CcSEcCtD
Ivacaftor—Transaminases increased—Epirubicin—sarcoma	0.00229	0.0131	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Thiotepa—sarcoma	0.00226	0.013	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Dactinomycin—sarcoma	0.00224	0.0129	CcSEcCtD
Ivacaftor—Transaminases increased—Doxorubicin—sarcoma	0.00211	0.0121	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Vincristine—sarcoma	0.002	0.0115	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Mitoxantrone—sarcoma	0.00195	0.0112	CcSEcCtD
Ivacaftor—Infestation—Thiotepa—sarcoma	0.00193	0.0111	CcSEcCtD
Ivacaftor—Infestation NOS—Thiotepa—sarcoma	0.00193	0.0111	CcSEcCtD
Ivacaftor—Hyperaesthesia—Epirubicin—sarcoma	0.00177	0.0102	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.00174	0.00998	CcSEcCtD
Ivacaftor—Connective tissue disorder—Thiotepa—sarcoma	0.0017	0.00978	CcSEcCtD
Ivacaftor—Hyperaesthesia—Doxorubicin—sarcoma	0.00164	0.00941	CcSEcCtD
Ivacaftor—Tinnitus—Thiotepa—sarcoma	0.00162	0.00928	CcSEcCtD
Ivacaftor—Mediastinal disorder—Thiotepa—sarcoma	0.00156	0.00897	CcSEcCtD
Ivacaftor—Connective tissue disorder—Vincristine—sarcoma	0.00151	0.00868	CcSEcCtD
Ivacaftor—Rhinitis—Mitoxantrone—sarcoma	0.0015	0.00862	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Epirubicin—sarcoma	0.00147	0.00844	CcSEcCtD
Ivacaftor—Infestation—Etoposide—sarcoma	0.00139	0.00797	CcSEcCtD
Ivacaftor—Infestation NOS—Etoposide—sarcoma	0.00139	0.00797	CcSEcCtD
Ivacaftor—Mediastinal disorder—Vincristine—sarcoma	0.00139	0.00796	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Doxorubicin—sarcoma	0.00136	0.00781	CcSEcCtD
Ivacaftor—Myalgia—Thiotepa—sarcoma	0.00129	0.00738	CcSEcCtD
Ivacaftor—Arthralgia—Thiotepa—sarcoma	0.00129	0.00738	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00128	0.00733	CcSEcCtD
Ivacaftor—Myalgia—Dactinomycin—sarcoma	0.00128	0.00732	CcSEcCtD
Ivacaftor—Infection—Thiotepa—sarcoma	0.00122	0.00703	CcSEcCtD
Ivacaftor—Infection—Dactinomycin—sarcoma	0.00121	0.00697	CcSEcCtD
Ivacaftor—Nervous system disorder—Thiotepa—sarcoma	0.00121	0.00694	CcSEcCtD
Ivacaftor—Skin disorder—Thiotepa—sarcoma	0.0012	0.00687	CcSEcCtD
Ivacaftor—Myalgia—Vincristine—sarcoma	0.00114	0.00654	CcSEcCtD
Ivacaftor—Mediastinal disorder—Etoposide—sarcoma	0.00112	0.00645	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00112	0.00644	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00111	0.0064	CcSEcCtD
Ivacaftor—Arthralgia—Mitoxantrone—sarcoma	0.00111	0.00637	CcSEcCtD
Ivacaftor—Myalgia—Mitoxantrone—sarcoma	0.00111	0.00637	CcSEcCtD
Ivacaftor—Infection—Vincristine—sarcoma	0.00109	0.00623	CcSEcCtD
Ivacaftor—Nervous system disorder—Vincristine—sarcoma	0.00107	0.00615	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Thiotepa—sarcoma	0.00106	0.00611	CcSEcCtD
Ivacaftor—Infection—Mitoxantrone—sarcoma	0.00106	0.00607	CcSEcCtD
Ivacaftor—Hypoglycaemia—Epirubicin—sarcoma	0.00103	0.00594	CcSEcCtD
Ivacaftor—Skin disorder—Mitoxantrone—sarcoma	0.00103	0.00593	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Thiotepa—sarcoma	0.00101	0.00578	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Dactinomycin—sarcoma	0.001	0.00574	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Vincristine—sarcoma	0.000995	0.00571	CcSEcCtD
Ivacaftor—Abdominal pain—Thiotepa—sarcoma	0.000974	0.00559	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000969	0.00557	CcSEcCtD
Ivacaftor—Abdominal pain—Dactinomycin—sarcoma	0.000966	0.00555	CcSEcCtD
Ivacaftor—Hypoglycaemia—Doxorubicin—sarcoma	0.000957	0.00549	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Vincristine—sarcoma	0.000943	0.00542	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000917	0.00526	CcSEcCtD
Ivacaftor—Breast disorder—Epirubicin—sarcoma	0.000912	0.00524	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000909	0.00522	CcSEcCtD
Ivacaftor—Nasopharyngitis—Epirubicin—sarcoma	0.000902	0.00518	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Vincristine—sarcoma	0.000893	0.00513	CcSEcCtD
Ivacaftor—Infection—Etoposide—sarcoma	0.000879	0.00505	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00087	0.005	CcSEcCtD
Ivacaftor—Abdominal pain—Vincristine—sarcoma	0.000864	0.00496	CcSEcCtD
Ivacaftor—Skin disorder—Etoposide—sarcoma	0.000859	0.00494	CcSEcCtD
Ivacaftor—Breast disorder—Doxorubicin—sarcoma	0.000844	0.00485	CcSEcCtD
Ivacaftor—Diarrhoea—Thiotepa—sarcoma	0.000843	0.00484	CcSEcCtD
Ivacaftor—Abdominal pain—Mitoxantrone—sarcoma	0.000841	0.00483	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000841	0.00483	CcSEcCtD
Ivacaftor—Diarrhoea—Dactinomycin—sarcoma	0.000837	0.0048	CcSEcCtD
Ivacaftor—Nasopharyngitis—Doxorubicin—sarcoma	0.000835	0.00479	CcSEcCtD
Ivacaftor—Dizziness—Thiotepa—sarcoma	0.000815	0.00468	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Epirubicin—sarcoma	0.000811	0.00466	CcSEcCtD
Ivacaftor—Infestation NOS—Epirubicin—sarcoma	0.000778	0.00447	CcSEcCtD
Ivacaftor—Infestation—Epirubicin—sarcoma	0.000778	0.00447	CcSEcCtD
Ivacaftor—Rash—Thiotepa—sarcoma	0.000777	0.00446	CcSEcCtD
Ivacaftor—Dermatitis—Thiotepa—sarcoma	0.000776	0.00446	CcSEcCtD
Ivacaftor—Headache—Thiotepa—sarcoma	0.000772	0.00443	CcSEcCtD
Ivacaftor—Rash—Dactinomycin—sarcoma	0.000771	0.00443	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Etoposide—sarcoma	0.000764	0.00439	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00075	0.00431	CcSEcCtD
Ivacaftor—Diarrhoea—Vincristine—sarcoma	0.000747	0.00429	CcSEcCtD
Ivacaftor—Nausea—Thiotepa—sarcoma	0.000732	0.0042	CcSEcCtD
Ivacaftor—Diarrhoea—Mitoxantrone—sarcoma	0.000728	0.00418	CcSEcCtD
Ivacaftor—Nausea—Dactinomycin—sarcoma	0.000726	0.00417	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Etoposide—sarcoma	0.000724	0.00415	CcSEcCtD
Ivacaftor—Dizziness—Vincristine—sarcoma	0.000722	0.00415	CcSEcCtD
Ivacaftor—Infestation NOS—Doxorubicin—sarcoma	0.00072	0.00413	CcSEcCtD
Ivacaftor—Infestation—Doxorubicin—sarcoma	0.00072	0.00413	CcSEcCtD
Ivacaftor—Rhinitis—Epirubicin—sarcoma	0.0007	0.00402	CcSEcCtD
Ivacaftor—Abdominal pain—Etoposide—sarcoma	0.000699	0.00402	CcSEcCtD
Ivacaftor—Rash—Vincristine—sarcoma	0.000689	0.00395	CcSEcCtD
Ivacaftor—Dermatitis—Vincristine—sarcoma	0.000688	0.00395	CcSEcCtD
Ivacaftor—Connective tissue disorder—Epirubicin—sarcoma	0.000686	0.00394	CcSEcCtD
Ivacaftor—Headache—Vincristine—sarcoma	0.000684	0.00393	CcSEcCtD
Ivacaftor—Rash—Mitoxantrone—sarcoma	0.000671	0.00385	CcSEcCtD
Ivacaftor—Dermatitis—Mitoxantrone—sarcoma	0.00067	0.00385	CcSEcCtD
Ivacaftor—Headache—Mitoxantrone—sarcoma	0.000666	0.00383	CcSEcCtD
Ivacaftor—Tinnitus—Epirubicin—sarcoma	0.000651	0.00374	CcSEcCtD
Ivacaftor—Nausea—Vincristine—sarcoma	0.000649	0.00373	CcSEcCtD
Ivacaftor—Rhinitis—Doxorubicin—sarcoma	0.000648	0.00372	CcSEcCtD
Ivacaftor—Connective tissue disorder—Doxorubicin—sarcoma	0.000635	0.00365	CcSEcCtD
Ivacaftor—Nausea—Mitoxantrone—sarcoma	0.000632	0.00363	CcSEcCtD
Ivacaftor—Mediastinal disorder—Epirubicin—sarcoma	0.000629	0.00361	CcSEcCtD
Ivacaftor—Diarrhoea—Etoposide—sarcoma	0.000605	0.00348	CcSEcCtD
Ivacaftor—Tinnitus—Doxorubicin—sarcoma	0.000602	0.00346	CcSEcCtD
Ivacaftor—Dizziness—Etoposide—sarcoma	0.000585	0.00336	CcSEcCtD
Ivacaftor—Mediastinal disorder—Doxorubicin—sarcoma	0.000582	0.00334	CcSEcCtD
Ivacaftor—Rash—Etoposide—sarcoma	0.000558	0.0032	CcSEcCtD
Ivacaftor—Dermatitis—Etoposide—sarcoma	0.000557	0.0032	CcSEcCtD
Ivacaftor—Headache—Etoposide—sarcoma	0.000554	0.00318	CcSEcCtD
Ivacaftor—Nausea—Etoposide—sarcoma	0.000526	0.00302	CcSEcCtD
Ivacaftor—Arthralgia—Epirubicin—sarcoma	0.000517	0.00297	CcSEcCtD
Ivacaftor—Myalgia—Epirubicin—sarcoma	0.000517	0.00297	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000514	0.00295	CcSEcCtD
Ivacaftor—Infection—Epirubicin—sarcoma	0.000493	0.00283	CcSEcCtD
Ivacaftor—Nervous system disorder—Epirubicin—sarcoma	0.000486	0.00279	CcSEcCtD
Ivacaftor—Skin disorder—Epirubicin—sarcoma	0.000482	0.00277	CcSEcCtD
Ivacaftor—Arthralgia—Doxorubicin—sarcoma	0.000479	0.00275	CcSEcCtD
Ivacaftor—Myalgia—Doxorubicin—sarcoma	0.000479	0.00275	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000475	0.00273	CcSEcCtD
Ivacaftor—Infection—Doxorubicin—sarcoma	0.000456	0.00262	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000452	0.00259	CcSEcCtD
Ivacaftor—Nervous system disorder—Doxorubicin—sarcoma	0.00045	0.00258	CcSEcCtD
Ivacaftor—Skin disorder—Doxorubicin—sarcoma	0.000446	0.00256	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Epirubicin—sarcoma	0.000428	0.00246	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000418	0.0024	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Epirubicin—sarcoma	0.000406	0.00233	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000396	0.00228	CcSEcCtD
Ivacaftor—Abdominal pain—Epirubicin—sarcoma	0.000392	0.00225	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Doxorubicin—sarcoma	0.000375	0.00216	CcSEcCtD
Ivacaftor—Abdominal pain—Doxorubicin—sarcoma	0.000363	0.00208	CcSEcCtD
Ivacaftor—Diarrhoea—Epirubicin—sarcoma	0.000339	0.00195	CcSEcCtD
Ivacaftor—Dizziness—Epirubicin—sarcoma	0.000328	0.00188	CcSEcCtD
Ivacaftor—Diarrhoea—Doxorubicin—sarcoma	0.000314	0.0018	CcSEcCtD
Ivacaftor—Rash—Epirubicin—sarcoma	0.000313	0.0018	CcSEcCtD
Ivacaftor—Dermatitis—Epirubicin—sarcoma	0.000312	0.00179	CcSEcCtD
Ivacaftor—Headache—Epirubicin—sarcoma	0.000311	0.00178	CcSEcCtD
Ivacaftor—Dizziness—Doxorubicin—sarcoma	0.000303	0.00174	CcSEcCtD
Ivacaftor—Nausea—Epirubicin—sarcoma	0.000295	0.00169	CcSEcCtD
Ivacaftor—Rash—Doxorubicin—sarcoma	0.000289	0.00166	CcSEcCtD
Ivacaftor—Dermatitis—Doxorubicin—sarcoma	0.000289	0.00166	CcSEcCtD
Ivacaftor—Headache—Doxorubicin—sarcoma	0.000288	0.00165	CcSEcCtD
Ivacaftor—Nausea—Doxorubicin—sarcoma	0.000273	0.00157	CcSEcCtD
